Stem Cells to combat aging
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
485
NCT02065245
AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 3, 2014
Completion: Oct 2, 2020
NCT02398604
Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
Phase: Phase 1
Start: Apr 30, 2015
Completion: Mar 31, 2019
NCT02600130
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
Start: Oct 10, 2016
Completion: Sep 30, 2021
NCT02982915
Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Start: Nov 30, 2016
Completion: Sep 30, 2022
NCT03169231
Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
Phase: Phase 2
Start: Jul 6, 2017
NCT03525418
Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
Start: Feb 21, 2018
Completion: Dec 31, 2025
NCT04629105
Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)
Start: Jul 24, 2020
Completion: Jul 31, 2025
NCT04925024
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
Start: Jun 25, 2021
Completion: Aug 31, 2026
NCT05233774
Lomecel-B Effects on Alzheimer's Disease
Start: Dec 28, 2021
Completion: Sep 29, 2023
NCT02587572
Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Start: Dec 1, 2023
Completion: Dec 31, 2023
Loading map...